Skip to main content
Top
Published in: International Journal of Hematology 2/2017

01-08-2017 | Images in Hematology

Marked hypereosinophilia and rash as initial presentation of acute myeloid leukemia with t(8;21)

Authors: Shin Yeu Ong, Liam Pock Ho, Pei Ming Yeo, Heng Joo Ng, Ai Leen Ang

Published in: International Journal of Hematology | Issue 2/2017

Login to get access

Excerpt

A 22-year-old woman presented with 1-month history of generalized pruritic dermatoses after taking weight loss supplements. The rash was unresponsive to steroids, and she developed low grade fever and malaise. She had no past history of eczema, allergic rhinitis, or atopy. On examination, there were multiple large, annular, infiltrated plaques with post-inflammatory hyperpigmentation over her arms, torso, and thighs (Fig. 1a, b). A full blood count showed mild anemia (Hb 11.4 g/L), leukocytosis (19.69 × 109/L) with marked eosinophilia (11.95 × 109/L), and moderate thrombocytopenia (68 × 109/L). Skin biopsy revealed eosinophil-rich perivascular infiltrates with no leukemic infiltrates. Peripheral blood film showed dysplastic eosinophils with hyperlobated nuclei, sparse granulation and abnormal blue granules (Fig. 1d–f). Occasional agranular blasts with basophilic cytoplasm were seen (Fig. 1g). The bone marrow aspirate was hypercellular with marked eosinophilia (27% eosinophil precursors) and 9% blasts (Fig. 1c). Flow cytometry detected 9% blasts expressing CD34, CD117, MPO, CD13, CD33 and aberrant CD19. Cytogenetic analysis showed t(8;21)(q22;q22) with no additional abnormalities. c-Kit mutation was negative. Molecular studies did not detect FIP1L1-PDGFRA or BCR-ABL rearrangements.
Literature
1.
go back to reference Boyer DF. Blood and bone marrow evaluation for eosinophilia. Arch Pathol Lab Med. 2016;140(10):1060–7.CrossRefPubMed Boyer DF. Blood and bone marrow evaluation for eosinophilia. Arch Pathol Lab Med. 2016;140(10):1060–7.CrossRefPubMed
2.
go back to reference Ishibashi T, Kimura H, Abe R, Matsuda S, Uchida T, Kariyone S. Involvement of eosinophils in leukemia: cytogenetic study of eosinophilic colonies from acute myelogenous leukemia associated with translocation (8;21). Cancer Genet Cytogenet. 1986;22(3):189–94.CrossRefPubMed Ishibashi T, Kimura H, Abe R, Matsuda S, Uchida T, Kariyone S. Involvement of eosinophils in leukemia: cytogenetic study of eosinophilic colonies from acute myelogenous leukemia associated with translocation (8;21). Cancer Genet Cytogenet. 1986;22(3):189–94.CrossRefPubMed
3.
go back to reference Ema H, Kitano K, Suda T, Sato Y, Muroi K, Ohta M, et al. In vitro differentiation of leukemic cells to eosinophils in the presence of interleukin-5 in two cases of acute myeloid leukemia with the translocation (8;21)(q22;q22). Blood. 1990;75:350–6.PubMed Ema H, Kitano K, Suda T, Sato Y, Muroi K, Ohta M, et al. In vitro differentiation of leukemic cells to eosinophils in the presence of interleukin-5 in two cases of acute myeloid leukemia with the translocation (8;21)(q22;q22). Blood. 1990;75:350–6.PubMed
Metadata
Title
Marked hypereosinophilia and rash as initial presentation of acute myeloid leukemia with t(8;21)
Authors
Shin Yeu Ong
Liam Pock Ho
Pei Ming Yeo
Heng Joo Ng
Ai Leen Ang
Publication date
01-08-2017
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2017
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-017-2230-4

Other articles of this Issue 2/2017

International Journal of Hematology 2/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine